Literature DB >> 6695737

Paradoxical angina after nifedipine: angiographic documentation.

P Schanzenbächer, P Deeg, G Liebau, K Kochsiek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6695737     DOI: 10.1016/0002-9149(84)90458-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  6 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  Comparison of haemodynamic effects of nifedipine and molsidomine in patients with coronary artery disease.

Authors:  M Kyriakidis; G Vyssoulis; P Sfikakis; C Kyriakidis; C Pitsavos; K Valsamis; V Nomikos; P Toutouzas
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Prevention of vasospastic angina with nicardipine.

Authors:  C J Pepine; J S Gelman
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Coronary vasomotor and clinical effects of nifedipine in effort, mixed and Prinzmental angina.

Authors:  A Polese; N De Cesare; A Bartorelli; F Fabbiocchi; A Loaldi; P Montorsi; M D Guazzi
Journal:  Int J Card Imaging       Date:  1988

6.  Preload or afterload reduction: which is more beneficial for patients with ischemic heart disease?

Authors:  D G Caralis; Z Kyriakides
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.